Biosynesis, Inc.

San Francisco, CA

UEI
MR1BLKLB8RV8
CAGE
6XSP6
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
44 Vicksburg St, San Francisco, CA 94114, USA
Website
biosynesis.com
Founded
2013
Employees
1-10
Estimated annual revenue
$0-$1M
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of protease activity-based detector substrates for diagnosing candida infections R41AI170132 National Institute of Allergy and Infectious Diseases (NIH) $896,113
Development of novel protease activity-based diagnostics for the rapid identification of candida infections R43AI131710 National Institute of Allergy and Infectious Diseases (NIH) $595,779
Development of therapeutics to treat candida albicans biofilm infections R41AI112038 National Institutes of Health $224,956

Quick answers

Is Biosynesis, Inc. registered in SAM.gov?

Yes. Biosynesis, Inc.'s SAM.gov registration is active through May 8, 2027.

What is Biosynesis, Inc.'s most recent federal award?

Biosynesis, Inc.'s most recent federal grant award is Development of protease activity-based detector substrates for diagnosing candida infections (R41AI170132), from National Institute of Allergy and Infectious Diseases (NIH), on August 3, 2022.

On GovTribe

See Biosynesis, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login